FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149227294> ?p ?o ?g. }

• W2149227294 endingPage "2461" @default.
• W2149227294 startingPage "2451" @default.
• W2149227294 abstract "Cyclosporins, in particular the nonimmunosuppressive derivative SDZ NIM 811, exhibit potent anti-human immunodeficiency virus type 1 (HIV-1) activity in vitro. SDZ NIM 811 interferes at two stages of the viral replication cycle: (i) translocation of the preintegration complex to the nucleus and (ii) production of infectious virus particles. Immunosuppressive activity is not correlated with anti-HIV-1 activity of cyclosporins. However, binding to cyclophilin A, the major cellular receptor protein of cyclosporins, is a prerequisite for HIV inhibition: all structural changes of the cyclosporin A molecule leading to loss of affinity to cyclophilin abolished the antiviral effect. Cyclosporin derivatives did not interact directly with HIV-1 proteins; cyclophilin was the only detectable receptor protein for antivirally active cyclosporins. There is no evidence that inhibition of HIV occurs via a gain of function of cyclophilin in the presence of cyclosporins: the complex of cyclophilin A with SDZ NIM 811 does not bind to calcineurin or to any other viral or cellular proteins under conditions in which calcineurin binding to the cyclophilin A-cyclosporin A complex is easily detectable. Thus, the loss of function caused by binding of cyclosporins to cyclophilin seems to be sufficient for the anti-HIV effect. Cyclophilin A was demonstrated to bind to HIV-1 p24gag, and the formation of complexes was blocked by cyclosporins with 50% inhibitory concentrations of about 0.7 microM. HIV-2 and simian immunodeficiency virus are only weakly or not at all inhibited by cyclosporins. For gag-encoded proteins derived from HIV-1, HIV-2, or simian immunodeficiency virus particles, cyclophilin-binding capacity correlated with sensitivity of the viruses to inhibition by cyclosporins. Cyclophilin A also binds to HIV-1 proteins other than gag-encoded proteins, namely, p17gag, Nef, Vif, and gp120env; the biological significance of these interactions is questionable. We conclude that HIV-1 Gag-cyclophilin A interaction may be essential in HIV-1 replication, and interference with this interaction may be the molecular basis for the antiviral activity of cyclosporins." @default.
• W2149227294 created "2016-06-24" @default.
• W2149227294 creator A5005072847 @default.
• W2149227294 creator A5006021208 @default.
• W2149227294 creator A5012157601 @default.
• W2149227294 creator A5014989436 @default.
• W2149227294 creator A5038950669 @default.
• W2149227294 creator A5073776776 @default.
• W2149227294 creator A5090058596 @default.
• W2149227294 date "1995-04-01" @default.
• W2149227294 modified "2023-10-02" @default.
• W2149227294 title "Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions" @default.
• W2149227294 cites W1493145825 @default.
• W2149227294 cites W1525971266 @default.
• W2149227294 cites W1545638435 @default.
• W2149227294 cites W1546971287 @default.
• W2149227294 cites W1584625273 @default.
• W2149227294 cites W1604062123 @default.
• W2149227294 cites W1661847997 @default.
• W2149227294 cites W1796915314 @default.
• W2149227294 cites W1873199501 @default.
• W2149227294 cites W1984754431 @default.
• W2149227294 cites W1987888541 @default.
• W2149227294 cites W1991670386 @default.
• W2149227294 cites W1993870517 @default.
• W2149227294 cites W1996103477 @default.
• W2149227294 cites W1996839499 @default.
• W2149227294 cites W2003239995 @default.
• W2149227294 cites W2019508559 @default.
• W2149227294 cites W2033186532 @default.
• W2149227294 cites W2034631046 @default.
• W2149227294 cites W2034805653 @default.
• W2149227294 cites W2040681869 @default.
• W2149227294 cites W2042544193 @default.
• W2149227294 cites W2043535732 @default.
• W2149227294 cites W2048077534 @default.
• W2149227294 cites W2049235751 @default.
• W2149227294 cites W2049463886 @default.
• W2149227294 cites W2050489828 @default.
• W2149227294 cites W2050652210 @default.
• W2149227294 cites W2058350611 @default.
• W2149227294 cites W2062639699 @default.
• W2149227294 cites W2063155149 @default.
• W2149227294 cites W2063825413 @default.
• W2149227294 cites W2076811542 @default.
• W2149227294 cites W2087809591 @default.
• W2149227294 cites W2089850443 @default.
• W2149227294 cites W2103368826 @default.
• W2149227294 cites W2111687259 @default.
• W2149227294 cites W2126350898 @default.
• W2149227294 cites W2152630682 @default.
• W2149227294 cites W2215812079 @default.
• W2149227294 cites W2316906870 @default.
• W2149227294 cites W2415706823 @default.
• W2149227294 cites W2418598064 @default.
• W2149227294 cites W2464283931 @default.
• W2149227294 cites W301185264 @default.
• W2149227294 cites W49920453 @default.
• W2149227294 doi "https://doi.org/10.1128/jvi.69.4.2451-2461.1995" @default.
• W2149227294 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/188920" @default.
• W2149227294 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7884893" @default.
• W2149227294 hasPublicationYear "1995" @default.
• W2149227294 type Work @default.
• W2149227294 sameAs 2149227294 @default.
• W2149227294 citedByCount "160" @default.
• W2149227294 countsByYear W21492272942012 @default.
• W2149227294 countsByYear W21492272942013 @default.
• W2149227294 countsByYear W21492272942014 @default.
• W2149227294 countsByYear W21492272942015 @default.
• W2149227294 countsByYear W21492272942016 @default.
• W2149227294 countsByYear W21492272942017 @default.
• W2149227294 countsByYear W21492272942018 @default.
• W2149227294 countsByYear W21492272942019 @default.
• W2149227294 countsByYear W21492272942021 @default.
• W2149227294 countsByYear W21492272942022 @default.
• W2149227294 countsByYear W21492272942023 @default.
• W2149227294 crossrefType "journal-article" @default.
• W2149227294 hasAuthorship W2149227294A5005072847 @default.
• W2149227294 hasAuthorship W2149227294A5006021208 @default.
• W2149227294 hasAuthorship W2149227294A5012157601 @default.
• W2149227294 hasAuthorship W2149227294A5014989436 @default.
• W2149227294 hasAuthorship W2149227294A5038950669 @default.
• W2149227294 hasAuthorship W2149227294A5073776776 @default.
• W2149227294 hasAuthorship W2149227294A5090058596 @default.
• W2149227294 hasBestOaLocation W21492272941 @default.
• W2149227294 hasConcept C104317684 @default.
• W2149227294 hasConcept C128057223 @default.
• W2149227294 hasConcept C140704245 @default.
• W2149227294 hasConcept C141071460 @default.
• W2149227294 hasConcept C147483822 @default.
• W2149227294 hasConcept C153911025 @default.
• W2149227294 hasConcept C159047783 @default.
• W2149227294 hasConcept C181199279 @default.
• W2149227294 hasConcept C195616568 @default.
• W2149227294 hasConcept C203014093 @default.
• W2149227294 hasConcept C2522874641 @default.
• W2149227294 hasConcept C2776258796 @default.
• W2149227294 hasConcept C2776326521 @default.

• next